outcomes research

Research in Review

PD-L1 Testing Uncommon Among NSCLC Patients on Immunotherapy

06/03/2017

JCP Editors

Few patients treated with immunotherapy for metastatic non–small cell lung cancer (NSCLC) at United States community practices receive appropriate programmed death-ligand 1 (PD-L1) expression testing, according to...

Few...

06/03/2017

Journal of Clinical Pathways

Research in Review

Adjuvant Chemo After Surgery Improves OS in Patients With NSCLC and Brain Metastasis

06/03/2017

JCP Editors

Patients with non-small cell lung cancer (NSCLC) and synchronous brain metastasis demonstrate improved 1-year and 5-year overall survival (OS) after thoracic surgery and systemic chemotherapy, according to research...

...

06/03/2017

Journal of Clinical Pathways

Research in Review

Combined Chemotherapy, Radiation Improves Survival in Locally Advanced Pancreatic Cancer

06/03/2017

JCP Editors

The addition of radiation therapy to chemotherapy improved overall survival (OS) in patients with unresected locally advanced pancreatic cancer, according to research presented at the 2017 ASCO Annual Meeting (June...

The...

06/03/2017

Journal of Clinical Pathways

Research in Review

Novel Therapy Induces High Response Rate in Metastatic NSCLC

06/01/2017

JCP Editors

A novel antibody-drug conjugate is well tolerated and induces durable responses in pretreated patients with advanced non-small cell lung cancer (NSCLC), according to research published in the Journal of Clinical...

A...

06/01/2017

Journal of Clinical Pathways

Research in Review

Receipt of Head, Neck Cancer Supportive Services Varies by Hospital Type

06/01/2017

JCP Editors

Patients with head and neck cancer who do not receive supportive services are more likely to miss radiation therapy appointments and lose weight during treatment, according to research presented at the 2017 ASCO...

...

06/01/2017

Journal of Clinical Pathways

Research in Review

Analyzing DLBCL Circulating Tumor DNA Helps Predict Treatment Response

05/31/2017

JCP Editors

Noninvasive sampling of diffuse large B-cell lymphoma (DLBCL) circulating tumor DNA enables early detection of focal and broad somatic copy number alterations, according to research that will be presented at the 2017...

...

05/31/2017

Journal of Clinical Pathways

Research in Review

Radiation Therapy Significantly Increases Survival in Type of B-Cell Malignancy

05/31/2017

JCP Editors

Patients with Hodgkin lymphoma who are treated with radiation therapy are more likely to survive the disease than those not treated with radiation therapy, according to a recent study published in Anticancer Research...

...

05/31/2017

Journal of Clinical Pathways

Research in Review

Previous Radiotherapy Improves Response to Immunotherapy in NSCLC

05/30/2017

JCP Editors

Patients with advanced non-small cell lung cancer (NSCLC) who receive previous radiotherapy are more likely to benefit from immunotherapy than those patients without previous radiotherapy, according to research...

...

05/30/2017

Journal of Clinical Pathways

Research in Review

B-Cell Malignancy Provides Economic Burden to US Commercial Payers

05/30/2017

JCP Editors

The high economic burden of B-cell malignancies on US commercial insurers may impact future reimbursement decisions, according to research that will be presented at the 2017 ASCO Annual Meeting (June 2-6, 2017;...

The...

05/30/2017

Journal of Clinical Pathways

Research in Review

HPV Vaccine Underutilized Despite Significant Oral HPV Infection Protection

05/30/2017

JCP Editors

Research presented at the 2017 American Society of Clinical Oncology showed that although human papillomavirus (HPV) vaccine reduces the rate of oral HPV infection, the vaccine is still underutilized among teens and...

...

05/30/2017

Journal of Clinical Pathways